New Products

CINCINNATI — Pampers, a Procter and Gamble brand, announced on Monday product upgrades across its entire line of diapers, training pants and wipes. The new product enhancements come after the company sponsored a survey of moms to address their concerns of unmet needs for their babies.

PARIS — Sanofi US and its consumer health business Chattem on Monday unveiled plans to re-introduce the iconic Rolaids heartburn-relief brand to the U.S. market. The brand returns after a three-year hiatus in the marketplace and follows Chattem's acquisition of Rolaids earlier this year.  

PARSIPPANY, N.J. — Actavis has launched a generic drug for post-shingles pain under an agreement with the branded drug's manufacturers, the company said Monday.

Actavis announced the launch of generic lidocaine topical patches in the 5% strength under a settlement agreement with Endo Pharmaceuticals and Teikoku Seiyaku Co. The drug is a generic version of Lidoderm, and Actavis said it was likely the first company to win approval for the generic from the Food and Drug Administration, thus entitling it to 180 days in which to compete exclusively against the branded version.

MUMBAI, India — The Food and Drug Administration has approved a drug made by Sun Pharmaceutical Industries for ulcers, Sun said.

Sun announced the approval of lansoprazole delayed-release capsules in the 15-mg and 30-mg strengths.

The drug is a generic version of Takeda's Prevacid delayed-release capsules, which are used for treatment lasting up to four weeks for healing and symptom relief of active duodenal ulcers.

Various versions of the drug have annual sales of about $430 million per year, according to Sun.

PARSIPPANY, N.J. — Actavis has launched a generic version of an extended-release opioid painkiller, the company said.

The drug maker announced the launch of oxymorphone extended-release tablets in the 5-mg, 10-mg, 20-mg, 30-mg and 40-mg strengths. Actavis received approval for the drug in July.

The drug is a generic version of Endo's Opana ER. Endo is currently suing Actavis, alleging that Actavis' generic infringes some of its patents. The drug is used for around-the-clock pain relief.

Madison, N.J. — ChapStick, part of the Pfizer portfolio of consumer brands, on Friday announced a new lip balm with advanced moisturizing and anti-aging ingredients.

BASEL, Switzerland — The Lonza Group recently launched its Alomune daily immune supplements into the U.S. market, backing the product with clinical trials that show the supplement helps improve the body’s natural defenses for optimized immune health. 

“Alomune works to naturally power your immune system and to keep it strong and more active,” stated Dan Johnston, brand spokesman.  

EMERYVILLE, Calif. — Clif on Thursday launched a new line of performance drinks: Clif Shot Electrolyte Hydration Drink Mix and Clif Shot Protein Recovery Drink Mix. In combination with Clif Shot Bloks and Clif Shot Energy Gel, the Clif Shot Portfolio now effectively covers athletes’ needs before, during and after activity.